Fuso Pharmaceutical Industries,Ltd. (4538.T)
JPY 2504.0
(-1.77%)
JPY 2504.0
(-1.77%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 7.02 Billion JPY | 22.17% |
| 2022 | 5.74 Billion JPY | -0.19% |
| 2021 | 5.75 Billion JPY | -13.28% |
| 2020 | 6.64 Billion JPY | -19.47% |
| 2019 | 8.24 Billion JPY | -12.2% |
| 2018 | 9.39 Billion JPY | 5.36% |
| 2017 | 8.91 Billion JPY | 7.49% |
| 2016 | 8.29 Billion JPY | 0.8% |
| 2015 | 8.22 Billion JPY | 60.1% |
| 2014 | 5.13 Billion JPY | -0.52% |
| 2013 | 5.16 Billion JPY | -16.63% |
| 2012 | 6.19 Billion JPY | -7.25% |
| 2011 | 6.67 Billion JPY | 16.44% |
| 2010 | 5.73 Billion JPY | -9.24% |
| 2009 | 6.32 Billion JPY | -2.74% |
| 2008 | 6.49 Billion JPY | -4.83% |
| 2007 | 6.82 Billion JPY | -10.46% |
| 2006 | 7.62 Billion JPY | -13.73% |
| 2005 | 8.84 Billion JPY | 23.46% |
| 2004 | 7.16 Billion JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 3.22 Billion JPY | -54.01% |
| 2023 Q4 | 7.02 Billion JPY | -11.8% |
| 2023 Q3 | 7.96 Billion JPY | 10.62% |
| 2023 FY | 7.02 Billion JPY | 22.17% |
| 2023 Q2 | 7.19 Billion JPY | 19.55% |
| 2023 Q1 | 6.01 Billion JPY | 4.73% |
| 2022 Q1 | 6.31 Billion JPY | 9.62% |
| 2022 Q4 | 5.74 Billion JPY | -6.11% |
| 2022 FY | 5.74 Billion JPY | -0.19% |
| 2022 Q3 | 6.12 Billion JPY | -4.97% |
| 2022 Q2 | 6.44 Billion JPY | 2.04% |
| 2021 Q3 | 6.7 Billion JPY | -5.59% |
| 2021 Q1 | 6.57 Billion JPY | -1.02% |
| 2021 Q2 | 7.1 Billion JPY | 8.06% |
| 2021 Q4 | 5.75 Billion JPY | -14.12% |
| 2021 FY | 5.75 Billion JPY | -13.28% |
| 2020 Q1 | 7.36 Billion JPY | -10.65% |
| 2020 Q4 | 6.64 Billion JPY | -13.84% |
| 2020 FY | 6.64 Billion JPY | -19.47% |
| 2020 Q3 | 7.7 Billion JPY | -6.25% |
| 2020 Q2 | 8.22 Billion JPY | 11.59% |
| 2019 Q4 | 8.24 Billion JPY | -12.39% |
| 2019 FY | 8.24 Billion JPY | -12.2% |
| 2019 Q1 | 9.19 Billion JPY | -2.07% |
| 2019 Q3 | 9.41 Billion JPY | -6.4% |
| 2019 Q2 | 10.05 Billion JPY | 9.32% |
| 2018 FY | 9.39 Billion JPY | 5.36% |
| 2018 Q1 | 9.22 Billion JPY | 3.55% |
| 2018 Q2 | 11.05 Billion JPY | 19.77% |
| 2018 Q3 | 10.55 Billion JPY | -4.55% |
| 2018 Q4 | 9.39 Billion JPY | -10.99% |
| 2017 FY | 8.91 Billion JPY | 7.49% |
| 2017 Q4 | 8.91 Billion JPY | -9.69% |
| 2017 Q3 | 9.86 Billion JPY | -4.8% |
| 2017 Q2 | 10.36 Billion JPY | 18.67% |
| 2017 Q1 | 8.73 Billion JPY | 5.35% |
| 2016 Q3 | 9.15 Billion JPY | -0.58% |
| 2016 Q1 | 9.04 Billion JPY | 9.9% |
| 2016 Q2 | 9.2 Billion JPY | 1.84% |
| 2016 FY | 8.29 Billion JPY | 0.8% |
| 2016 Q4 | 8.29 Billion JPY | -9.41% |
| 2015 Q2 | 8.71 Billion JPY | 65.24% |
| 2015 Q3 | 8.87 Billion JPY | 1.86% |
| 2015 Q4 | 8.22 Billion JPY | -7.33% |
| 2015 Q1 | 5.27 Billion JPY | 2.65% |
| 2015 FY | 8.22 Billion JPY | 60.1% |
| 2014 Q2 | 6 Billion JPY | 35.68% |
| 2014 Q3 | 5.94 Billion JPY | -0.88% |
| 2014 FY | 5.13 Billion JPY | -0.52% |
| 2014 Q1 | 4.42 Billion JPY | -14.37% |
| 2014 Q4 | 5.13 Billion JPY | -13.62% |
| 2013 FY | 5.16 Billion JPY | -16.63% |
| 2013 Q4 | 5.16 Billion JPY | -13.74% |
| 2013 Q1 | 5.39 Billion JPY | -12.95% |
| 2013 Q2 | 6.35 Billion JPY | 17.91% |
| 2013 Q3 | 5.98 Billion JPY | -5.83% |
| 2012 Q3 | 7.07 Billion JPY | -2.64% |
| 2012 Q4 | 6.19 Billion JPY | -12.45% |
| 2012 Q2 | 7.26 Billion JPY | 5.7% |
| 2012 Q1 | 6.87 Billion JPY | 2.95% |
| 2012 FY | 6.19 Billion JPY | -7.25% |
| 2011 Q3 | 7.36 Billion JPY | -4.92% |
| 2011 FY | 6.67 Billion JPY | 16.44% |
| 2011 Q1 | 5.01 Billion JPY | -12.66% |
| 2011 Q2 | 7.74 Billion JPY | 54.57% |
| 2011 Q4 | 6.67 Billion JPY | -9.29% |
| 2010 Q3 | 6.21 Billion JPY | -8.55% |
| 2010 Q1 | 6.12 Billion JPY | -3.1% |
| 2010 FY | 5.73 Billion JPY | -9.24% |
| 2010 Q4 | 5.73 Billion JPY | -7.69% |
| 2010 Q2 | 6.79 Billion JPY | 10.96% |
| 2009 Q3 | 6.64 Billion JPY | -9.06% |
| 2009 Q4 | 6.32 Billion JPY | -4.88% |
| 2009 Q2 | 7.3 Billion JPY | 0.0% |
| 2009 FY | 6.32 Billion JPY | -2.74% |
| 2008 Q4 | 6.49 Billion JPY | -7.54% |
| 2008 FY | 6.49 Billion JPY | -4.83% |
| 2008 Q3 | 7.02 Billion JPY | 0.0% |
| 2007 FY | 6.82 Billion JPY | -10.46% |
| 2006 FY | 7.62 Billion JPY | -13.73% |
| 2005 FY | 8.84 Billion JPY | 23.46% |
| 2004 FY | 7.16 Billion JPY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 1.23 Billion JPY | -470.349% |
| Takeda Pharmaceutical Company Limited | 4476.5 Billion JPY | 99.843% |
| Sumitomo Pharma Co., Ltd. | 133.36 Billion JPY | 94.736% |
| Shionogi & Co., Ltd. | 8.75 Billion JPY | 19.788% |
| Wakamoto Pharmaceutical Co.,Ltd. | - JPY | -Infinity% |
| Nippon Shinyaku Co., Ltd. | 1.15 Billion JPY | -509.462% |
| Kaken Pharmaceutical Co., Ltd. | - JPY | -Infinity% |
| Eisai Co., Ltd. | 134.77 Billion JPY | 94.79% |
| Morishita Jintan Co., Ltd. | 106 Million JPY | -6523.585% |
| Hisamitsu Pharmaceutical Co., Inc. | 76 Million JPY | -9138.158% |
| Mochida Pharmaceutical Co., Ltd. | - JPY | -Infinity% |
| Nippon Chemiphar Co., Ltd. | 13.34 Billion JPY | 47.385% |
| Tsumura & Co. | 54.37 Billion JPY | 87.088% |
| Kissei Pharmaceutical Co., Ltd. | - JPY | -Infinity% |
| Torii Pharmaceutical Co., Ltd. | 22 Million JPY | -31813.636% |
| Towa Pharmaceutical Co., Ltd. | 189.12 Billion JPY | 96.288% |
| Fuji Pharma Co., Ltd. | 11.92 Billion JPY | 41.119% |
| Zeria Pharmaceutical Co., Ltd. | 7.94 Billion JPY | 11.617% |
| KYORIN Holdings, Inc. | 435 Million JPY | -1514.023% |
| Taiko Pharmaceutical Co.,Ltd. | 2.74 Billion JPY | -156.147% |
| Daito Pharmaceutical Co.,Ltd. | 4.66 Billion JPY | -50.375% |
| SymBio Pharmaceuticals Limited | - JPY | -Infinity% |
| MedRx Co., Ltd | - JPY | -Infinity% |
| Mizuho Medy Co.,Ltd. | - JPY | -Infinity% |
| Solasia Pharma K.K. | 27 Million JPY | -25903.704% |
| Modalis Therapeutics Corporation | 412.5 Million JPY | -1602.061% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 4.5 Billion JPY | -55.849% |
| Sawai Group Holdings Co., Ltd. | 66.84 Billion JPY | 89.496% |
| Cyfuse Biomedical K.K. | 345 Million JPY | -1935.072% |
| Toho Holdings Co., Ltd. | 28.16 Billion JPY | 75.073% |
| Koa Shoji Holdings Co.,Ltd. | 1.59 Billion JPY | -341.188% |